Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2026

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	September 30, 2026		December 31, 2025
Seller earnout and deferred acquisition consideration	$	87.0	$	2.6
Personnel and restructuring costs	81.3		114.1
Commercial costs	19.5		18.9
Warranty costs	25.4		24.5
Accrued interest	27.7		46.4
Right-of-use liabilities	24.9		19.9
Insurance and professional fees	29.3		19.5
Income tax payable	0.8		5.4
Other	73.4		13.9
Total	$	369.3	$	265.2

During the quarter ended June 30, 2026, the Company reclassified $84.7 of seller earnouts related to the AprilAire Acquisition from other long-term liabilities to accrued expenses and other current liabilities as the amounts will become due within the next 12 months.

During the quarter ended September 30, 2026, the Company entered into derivative instruments in connection with the proposed acquisition of ebm-papst. As of September 30, 2026, the current portion of derivative liabilities related to the ebm-papst Acquisition was $46.2 and is included in Other in the table above. Refer to Note 12. Derivative Financial Instruments for additional information.